About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
About
Mission/Vision
Our Team
Board of Directors
Elite Members
Partnerships
Membership
Why Join BioUtah?
Membership Prospectus
Member Login
Apply for Membership
Savings Program
Non-dilutive Funding
Membership Directory
Advocacy
Bill Tracker
News/Info
Life Sciences News
Biosphere
Magazine
Podcasts
Reports/Publications
Events
BioUtah Events
Industry Events
Subscribe
Join Now
Utah Life Sciences News & Events
July 18, 2025
July 21, 2025
This week’s newsletter included:
U.S. SBA Holds Life Sciences Roundtable
Utah Business
2025-2026 Editorial Advisory Board Includes Kelvyn Cullimore
Utah Business
Opens Nominations for 2025 Best Companies to Work For Awards
Canary Speech Selected as Partner Company for LG NOVA 2024–2025 Mission for the Future
TIME
Lists America’s Best Mid-Size Companies of 2025
New Intern Introduction: Grace Gibby
BioUtah Members – We’re Upgrading Our CRM
U of U Health Researchers Find Link Between Air Pollution and Risk of Brain Bleed
CivicaScript® Launches Low-Cost Cancer Drug
Purgo Scientific Appoints Industry Leader Tim Nieman to Board of Directors
Crossing the Valley of Death: Part One
Microvascular Therapeutics Celebrates Major Achievements at ASE 2025
Utah Rare Disease Advisory Council Gets New Leadership
Tech Tuesday Recap: Where Academia Meets Innovation
University of Utah Founders Day Distinguished Alumni Awards
Brain-to-Text ’25 Competition
Recent News
Kolosis BIO® Expands Surgical Biologics Portfolio with Launch of APEXecm™
Myriad Genetics Receives FDA Approval of the MyChoice CDx Test as the Companion Diagnostic for Zejula (niraparib) for Patients with Ovarian Cancer
Merit Medical Launches the Resilience Through-the-Scope Esophageal Stent
Glafabra Therapeutics Receives FDA Orphan Drug Designation for GT-GLA-S03, Advancing a Redosable Cell Therapy for Fabry Disease
BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO® (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)